Trupanion will report 2025 financial results on February 12, 2026, followed by a conference call and webcast.
Quiver AI Summary
Trupanion, Inc. has announced it will release its financial results for the fourth quarter and full year of 2025 on February 12, 2026, after the market closes. A conference call is scheduled for the same day at 1:30 p.m. PT, where the company's results, guidance, and management insights will be discussed. This call will be accessible via a live webcast on Trupanion's Investor Relations website, with an archived version available for three months. Participants can join the call by phone using designated numbers for the U.S. and international callers, with a telephonic replay option also available. Trupanion, a leader in medical insurance for pets with over one million enrolled, provides direct payment technology to veterinarians, ensuring pet owners can focus on their pets' health rather than financial concerns.
Potential Positives
- Trupanion will report its financial results for the fourth quarter and full year of 2025, indicating transparency and accountability to investors.
- The company has over 1,000,000 pets currently enrolled, showcasing its strong market position and customer trust in its services.
- Trupanion offers a unique service by being able to pay veterinarians directly at the time of checkout, enhancing customer convenience and satisfaction.
Potential Negatives
- The release lacks specific details about expected financial performance, which could lead to concerns about transparency and investor confidence ahead of the earnings call.
- There is no mention of any updates or improvements in business operations or future strategies, which might raise questions about the company's direction and growth potential.
- The announcement does not highlight any significant achievements or milestones reached in the past year, potentially leaving investors and stakeholders seeking more positive news about the company's performance.
FAQ
When will Trupanion announce its 2025 financial results?
Trupanion will report its 2025 fourth quarter and full year financial results on February 12, 2026, after market close.
How can I access Trupanion's conference call?
Access the conference call by dialing 1-844-676-1342 for the US or 1-412-634-6683 for international participants.
Is there a webcast available for Trupanion's financial results?
Yes, a live webcast will be available on Trupanion's Investor Relations site and archived for 3 months after the call.
What is Trupanion's core business?
Trupanion specializes in medical insurance for cats and dogs, providing coverage across the US, Canada, and parts of Europe.
How can I find more information about Trupanion?
Visit Trupanion's website at trupanion.com for more information about their policies and services.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TRUP Insider Trading Activity
$TRUP insiders have traded $TRUP stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $TRUP stock by insiders over the last 6 months:
- DARRYL RAWLINGS has made 0 purchases and 2 sales selling 50,000 shares for an estimated $2,236,725.
- MARGARET TOOTH (CEO) has made 0 purchases and 8 sales selling 37,253 shares for an estimated $1,473,804.
- FAWWAD QURESHI (Chief Financial Officer) has made 0 purchases and 3 sales selling 15,453 shares for an estimated $638,704.
- JOHN R GALLAGHER (Chief Operating Officer) has made 0 purchases and 2 sales selling 6,813 shares for an estimated $238,429.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TRUP Revenue
$TRUP had revenues of $366.9M in Q3 2025. This is an increase of 12.05% from the same period in the prior year.
You can track TRUP financials on Quiver Quantitative's TRUP stock page.
$TRUP Hedge Fund Activity
We have seen 99 institutional investors add shares of $TRUP stock to their portfolio, and 116 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 1,390,446 shares (-68.2%) from their portfolio in Q3 2025, for an estimated $60,178,502
- BALYASNY ASSET MANAGEMENT L.P. added 846,784 shares (+188.5%) to their portfolio in Q3 2025, for an estimated $36,648,811
- BAILLIE GIFFORD & CO removed 599,110 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $25,929,480
- MILLENNIUM MANAGEMENT LLC added 402,421 shares (+185.8%) to their portfolio in Q3 2025, for an estimated $17,416,780
- BANK OF AMERICA CORP /DE/ removed 317,186 shares (-24.3%) from their portfolio in Q3 2025, for an estimated $13,727,810
- PALISADE CAPITAL MANAGEMENT, LP removed 237,777 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,290,988
- DF DENT & CO INC removed 234,877 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,165,476
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TRUP Price Targets
Multiple analysts have issued price targets for $TRUP recently. We have seen 3 analysts offer price targets for $TRUP in the last 6 months, with a median target of $42.0.
Here are some recent targets:
- Ryan Tunis from Cantor Fitzgerald set a target price of $42.0 on 01/14/2026
- John Barnidge from Piper Sandler set a target price of $60.0 on 12/19/2025
- Jonathan Block from Stifel set a target price of $42.0 on 11/18/2025
Full Release
SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 fourth quarter and full year after the market closes on Thursday, February 12, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET.
A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site.
Participants can access the conference call by dialing 1-844-676-1342 (United States) or 1-412-634-6683 (International). A telephonic replay of the call will also be available after the completion of the call, by dialing 1-844-512-2921 (United States) or 1-412-317-6671 (International) and entering the replay pin number: 10204830.
About Trupanion
Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, and certain countries in Continental Europe with over 1,000,000 pets currently enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet parents with the highest value in pet medical insurance with unlimited payouts for the life of their pets. With its patented process, Trupanion is the only North American provider with the technology to pay veterinarians directly in seconds at the time of checkout. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company or ZPIC Insurance Company and, in Canada, by Accelerant Insurance Company of Canada or GPIC Insurance Company. Policies are sold and administered in Canada by Canada Pet Health Insurance Services, Inc. dba Trupanion 309-1277 Lynn Valley Road, North Vancouver, BC V7J 0A2 and in the United States by Trupanion Managers USA, Inc. (CA license No. 0G22803, NPN 9588590). Canada Pet Health Insurance Services, Inc. is a registered damage insurance agency and claims adjuster in Quebec #603927. For more information, please visit trupanion.com.
Contacts
Laura Bainbridge, Senior Vice President, Corporate Communications
Gil Melchior, Director, Investor Relations
[email protected]
